OXIDATION CHEMISTRY OF INDOLES
吲哚的氧化化学
基本信息
- 批准号:2176541
- 负责人:
- 金额:$ 25.35万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1983
- 资助国家:美国
- 起止时间:1983-09-15 至 1995-08-31
- 项目状态:已结题
- 来源:
- 关键词:5 hydroxytryptophan Alzheimer's disease autooxidation brain mapping brain metabolism catecholamine inhibitor cell components disease /disorder model dorsal raphe nucleus drug screening /evaluation electrical potential electrochemistry high performance liquid chromatography histochemistry /cytochemistry hydroxyindoleacetate hydroxyl group immunocytochemistry indoles infrared spectrometry laboratory mouse laboratory rat locus coeruleus mass spectrometry neural degeneration neurotoxins neurotransmitter metabolism neurotransmitter receptor nuclear magnetic resonance spectroscopy oxidation peroxidases receptor binding serotonin serotonin inhibitor serotonin receptor toxicant screening tryptophan analog
项目摘要
The chemical or biochemical processes which cause degeneration of rather
selective areas of the brain in Alzheimer's Disease (AD) are unknown. It
is known, however, that there is a serious serotonergic dysfunction in AD.
Furthermore, the indolic neurotransmitter 5-hydroxytryptamine (5-HT) and
related central indoles are easily oxidized compounds. Some oxidation
products when centrally administered to mice evoke profound behavioral
responses, and cause transmitter depletions and/or metabolite disruptions
in the catecholaminergic, serotonergic and cholinergic neuronal systems,
i.e., systems most profoundly affected in AD. Unidentified but oxidized
forms of 5-HT and other central indoles are present in cerebrospinal fluid
of AD patients but not in that of age-matched controls. And, conditions
appear to exist in Alzheimer brain tissue which should facilitate oxidation
reactions. Taken together this evidence leads to a hypothesis that a
defect in the serotonergic system in Alzheimer brain results in aberrant
oxidations of central indoles forming toxins. The hypothesis further
proposes that these toxins attack not only the parent serotonergic neurons,
principally the raphe nuclei, but are released and attack the physically
proximate noradrenergic locus coeruleus and the cholinergic nucleus basalis
complex. These three structures originate in the isodendritic core and
project to cortical regions of the brain and are rather selectively
degenerated in AD.
The specific aims of this proposal are to elucidate the oxidation chemistry
and biochemistry of the central indoles under experimental conditions which
might be relevant to those which exist in alzheimer brain tissue.
Resulting products will be screened for toxicity and behavioral response
following central administration to mice and rats. The effects of active
drugs on the catecholaminergic serotonergic, and cholinergic neuronal
systems will be investigated by neurotransmitter/metabolite analyses. In
order to more fully understand the mode of action of active drugs, studies
of transmitter uptake/release processes, effects on key biosynthetic and
biodegradative enzymes, and on CNS receptors are planned. Histochemical
and microscopic studies will be employed to assess specific regions of
neuronal damage or destruction. Chemical mechanisms underlying the toxic
effects of certain active drugs will be investigated. Evidence will also
be sought to demonstrate that central indoles undergo oxidation reactions
even under conditions of non-pathological aging, reactions which may be
greatly accelerated in AD. Ultimately, it is expected that these studies
might provide important insights into some aspects of the neuronal
degeneration and biochemical defects underlying AD.
生物化学,生物化学引起的化学或生化过程
阿尔茨海默病(AD)的大脑选择性区域尚不清楚。它
然而,已知在AD中存在严重的5-羟色胺能功能障碍。
此外,吲哚类神经递质5-羟色胺(5-HT)和
相关的中心吲哚是容易被氧化的化合物。一些氧化作用
当产品集中在小鼠身上时,会引起深刻的行为学
反应,并导致递质耗竭和/或代谢物中断
在儿茶酚胺能、5-羟色胺能和胆碱能神经元系统中,
即在AD中受影响最深的系统。身份不明,但已被氧化
脑脊液中存在多种形式的5-羟色胺和其他中枢吲哚
而在年龄匹配的对照组中则不是。和,条件
似乎存在于阿尔茨海默病脑组织中,这应该会促进氧化
反应。综上所述,这些证据导致了一种假设
阿尔茨海默病患者脑内5-羟色胺能系统缺陷导致异常
中心吲哚的氧化形成毒素。该假说进一步
提出这些毒素不仅攻击亲代的5-羟色胺能神经元,
主要是中缝核团,但被释放并攻击身体
去甲肾上腺素能蓝斑和胆碱能基底核
很复杂。这三种结构起源于等树枝状核,
投射到大脑的皮质区域,而且相当有选择性
在公元后退化。
这项提议的具体目的是阐明氧化化学。
以及在实验条件下的中心吲哚的生物化学
可能与阿尔茨海默病脑组织中存在的那些相关。
产生的产品将进行毒性和行为反应筛查
在小鼠和大鼠集中给药后。主动性的影响
儿茶酚胺能、5-羟色胺能和胆碱能神经元的药物
系统将通过神经递质/代谢物分析进行研究。在……里面
为了更全面地了解活性药物的作用方式,研究
递质摄取/释放过程,对关键生物合成和
生物降解酶和中枢神经系统受体是计划的。组织化学
并将利用微观研究来评估特定的区域
神经元损伤或破坏。毒物背后的化学机制
某些活性药物的效果将被调查。证据也会
试图证明中心吲哚发生氧化反应
即使在非病理性老化的条件下,反应也可能是
在公元后大大加速。最终,预计这些研究将
可能会对神经元的某些方面提供重要的见解
变性和生化缺陷是阿尔茨海默病的基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GLENN DRYHURST其他文献
GLENN DRYHURST的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GLENN DRYHURST', 18)}}的其他基金
TANDEM MASS SPECTROMETER FOR BIOMOLECULAR ANALYSIS
用于生物分子分析的串联质谱仪
- 批准号:
2791802 - 财政年份:1999
- 资助金额:
$ 25.35万 - 项目类别:
GAS CHROMATOGRAPH-MASS SPECTROMETER-DATA SYSTEM
气相色谱-质谱仪-数据系统
- 批准号:
3519241 - 财政年份:1985
- 资助金额:
$ 25.35万 - 项目类别:
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Discovering early biomarkers of Alzheimer's disease using genetic and physics-informed networks
利用遗传和物理信息网络发现阿尔茨海默病的早期生物标志物
- 批准号:
2904538 - 财政年份:2024
- 资助金额:
$ 25.35万 - 项目类别:
Studentship
Deciphering electrophysiological Alzheimer's Disease biomarkers for early diagnosis using interpretable deep learning
使用可解释的深度学习破译电生理阿尔茨海默病生物标志物以进行早期诊断
- 批准号:
24K18602 - 财政年份:2024
- 资助金额:
$ 25.35万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
DMS/NIGMS 1: Multilevel stochastic orthogonal subspace transformations for robust machine learning with applications to biomedical data and Alzheimer's disease subtyping
DMS/NIGMS 1:多级随机正交子空间变换,用于稳健的机器学习,应用于生物医学数据和阿尔茨海默病亚型分析
- 批准号:
2347698 - 财政年份:2024
- 资助金额:
$ 25.35万 - 项目类别:
Continuing Grant
Investigating And Targeting Microglial Senescence In Alzheimer's Disease
研究并针对阿尔茨海默病中的小胶质细胞衰老
- 批准号:
MR/Y004116/1 - 财政年份:2024
- 资助金额:
$ 25.35万 - 项目类别:
Research Grant
Development of novel macrocyclic BACE1 inhibitors for preventive or therapeutic agents for Alzheimer's disease
开发用于预防或治疗阿尔茨海默病的新型大环 BACE1 抑制剂
- 批准号:
23K06058 - 财政年份:2023
- 资助金额:
$ 25.35万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Incorporating Diversity in Alzheimer's Disease Research: Developing Representative and Generalizable models
将多样性纳入阿尔茨海默病研究:开发代表性和可推广的模型
- 批准号:
495662 - 财政年份:2023
- 资助金额:
$ 25.35万 - 项目类别:
Operating Grants
Histone variant macroH2A1 as a novel regulator of memory deficits in Alzheimer's disease
组蛋白变体 MacroH2A1 作为阿尔茨海默病记忆缺陷的新型调节剂
- 批准号:
478226 - 财政年份:2023
- 资助金额:
$ 25.35万 - 项目类别:
Operating Grants
Investigation of treatment and prevention methods for Alzheimer's disease targeting orexin neurons
针对食欲素神经元的阿尔茨海默病治疗和预防方法的研究
- 批准号:
23K14364 - 财政年份:2023
- 资助金额:
$ 25.35万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The role of testosterone signaling in microglia: a potential role for sex differences in Alzheimer's Disease
睾酮信号在小胶质细胞中的作用:性别差异在阿尔茨海默病中的潜在作用
- 批准号:
23KJ1699 - 财政年份:2023
- 资助金额:
$ 25.35万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Targeting Circadian Clock Dysfunction in Alzheimer's Disease (TClock4AD)
针对阿尔茨海默氏病的生物钟功能障碍 (TClock4AD)
- 批准号:
EP/X030091/1 - 财政年份:2023
- 资助金额:
$ 25.35万 - 项目类别:
Research Grant














{{item.name}}会员




